Sort
21,453 grants matching “tuberculosis”
RP2: Targeting genes and pathways for autophagy-dependent inhibition of bacterial infection
$1,480,332Ramnik J Xavier · Ut Southwestern Medical Center · U19 · FY2019 · AI
International Epi Databases to Evaluate AIDS (IEDEA) in central Africa (Region 9)
$1,480,130Godfrey Woelk · Research Triangle Institute · U01 · FY2009 · AI
Sample Processing Cartridges for Rapid PCR TB Detection
$1,479,189David Alland · Cepheid · R42 · FY2006 · AI
JOHNS HOPKINS ADULT AIDS CLINICAL TRIALS UNIT
$1,478,841Johns Hopkins University · U01 · FY2003 · AI
San Francisco Bay Clinical Trials Unit (CTU)
$1,477,862Susan Buchbinder · Public Health Foundation Enterprises · UM1 · FY2025 · AI
Observational Antiretroviral Studies In Southern Africa (OASIS) Collaboration
$1,477,358Matthias Egger · Universitat Bern · U01 · FY2008 · AI
NATURAL HISTORY OF HIV INFECTION IN IVDUS
$1,476,592Montefiore Medical Center (Bronx, Ny) · R01 · FY2000 · DA
BUILDING GLOBAL CAPACITY FOR DIAGNOSTIC TESTING OF TUBERCULOSIS, MALARIA AND HIV
$1,476,153Heidi Albert · Foundation/Innovative New Diagnostics · U2G · FY2013 · PS
Adjuvant Development in the context of a vaccine to protect against tuberculosis
$1,473,199Nikolai Petrovsky · Vaxine Pty Ltd · N01 · FY2020 · AI
Stellenbosch University Clinical Trial Unit, Cape Town, South Africa
$1,471,428Mark Fredric Cotton · Stellenbosch University · U01 · FY2008 · AI
MIAMI ADULT AIDS CLINICAL TRIALS GROUP, AACTG
$1,471,122University Of Miami School Of Medicine · U01 · FY2004 · AI
DRAMATIC Phase 2 Duration Randomized MDR-TB Treatment Trial
$1,470,699Payam Nahid · University Of California, San Francisco · U01 · FY2020 · AI
Immunopathogenic Mechanisms of Human Immunodeficiency Virus (HIV) Disease
$1,470,482Irini Sereti · National Institute Of Allergy And Infectious Diseases · ZIA · FY2025 · AI
VIRGINIA DEPT OF HEALTH, TUBERCULOSIS COOPERATIVE AGREEMENT
$1,470,152Kathryin Hafford · Virginia State Dept Of Health · U52 · FY2012 · PS
Developing Teixobactin for Respiratory Infections
$1,469,494Dallas Hughes · Novobiotic Pharmaceuticals, Llc · R01 · FY2021 · AI
Experimental Animal Models of TB: Chemotherapeutics and Imaging
$1,469,455Clifton Barry · National Institute Of Allergy And Infectious Diseases · ZIA · FY2020 · AI
Development Of New Chemotherapeutics For Tuberculosis
$1,469,455Clifton Barry · National Institute Of Allergy And Infectious Diseases · ZIA · FY2020 · AI
Machine learning and artificial intelligence research for clinical medical image processing
$1,468,597Sameer Antani · National Library Of Medicine · ZIA · FY2023 · LM
Sputum Transcriptomic Expression Profiling in Study 31: Express 31
$1,468,225Payam Nahid · University Of California, San Francisco · R01 · FY2019 · AI
Phase II: Development of Low-Cost, Shelf-Stable Treatment for Tuberculosis
$1,468,122Zachary Warnken · Via Therapeutics, Llc · N44 · FY2023 · AI
TUBERCULOSIS ELIMINATION AND LABORATORY
$1,466,950Kim W Field · Washington State Depart Soc/Hlth Srvs · U52 · FY2009 · PS
Human monoclonal antibodies targeting infectious pathogens
$1,466,586Joshua Hoong Yu Tan · National Institute Of Allergy And Infectious Diseases · ZIA · FY2022 · AI
COLUMBIA-ADARC-CORNELL AIDS CLINICAL TRIALS UNIT
$1,466,318Columbia University Health Sciences · U01 · FY2002 · AI
TUBERCULOSIS PREVENTION RESEARCH UNIT
$1,465,057W. Henry Henry Boom · · N01 · FY2007 · AI
Tuberculosis Elimination and Laboratory Cooperative Agreement Application (Illinois, outside of Chicago)
$1,464,902Fredrick Echols · Illinois State Dept Of Public Health · U52 · FY2015 · PS